NIST Selects BBI Nanoparticles
The National Institute of Standards and Technology (NIST) has selected gold nanoparticles made by BBInternational (BBI), based in England, as the source of reference materials for preclinical biomedical research. The US agency will use colloidal gold nanoparticles made by BBI to create nanoscale materials for the evaluation and qualification of methodology and instrument performance. This will enable companies involved in research and diagnostics to ensure that their equipment is performing within the required quality-control parameters for the measurement and characterization of nanoparticles. BBInternational makes spherical, mono disperse gold nanoparticles that are widely used in rapid lateral flow assays.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024